Budaörs, Hungary

Jozsef Kokosi

This inventor holds 8 USPTO granted patents. Top assignee: Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.. Active years: 1983-1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jozsef Kokosi. Retrieved from https://idiyas.com/inventor/jozsef-kokosi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1983-1986

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Jozsef Kokosi: Innovator in Pharmaceutical Chemistry

Introduction

Jozsef Kokosi is a notable inventor based in Budaors, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 8 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest inventions are bronchodilatory azepino(1,2-A)pyrimidine derivatives and acid addition salts. This invention relates to new azepino[1,2-a]pyrimidine derivatives, characterized by a specific general formula. These compounds can be synthesized from 3-substituted-2-oxo-tetrahydro-pyrrol[1,2-a]pyrimidines, which are also part of his research.

Career Highlights

Jozsef Kokosi has built a successful career at Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt., a prominent pharmaceutical company. His expertise in developing new chemical entities has positioned him as a key player in the industry.

Collaborations

Throughout his career, Jozsef has collaborated with esteemed colleagues, including Istvan Hermecz and Agnes Horvath. These partnerships have fostered a collaborative environment that enhances innovation and research.

Conclusion

Jozsef Kokosi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…